Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Fresenius Medical Care AG & Co. KGaA (0H9X) was downgraded to a Hold Rating at Goldman Sachs

Tipranks - Tipranks - Wed Jan 21, 8:48AM CST

Fresenius Medical Care AG & Co. KGaA received a Hold rating and a €40.00 price target from Goldman Sachs analyst Richard Felton today.

Claim 50% Off TipRanks Premium

Felton covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, Smith & Nephew, and ConvaTec. According to TipRanks, Felton has an average return of 6.8% and a 59.13% success rate on recommended stocks.

In addition to Goldman Sachs, Fresenius Medical Care AG & Co. KGaA also received a Hold from Kepler Capital ‘s Oliver Reinberg in a report issued on January 13. However, on January 14, UBS maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

See today’s best-performing stocks on TipRanks >>

Based on Fresenius Medical Care AG & Co. KGaA’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of €4.88 billion and a net profit of €274.8 million. In comparison, last year the company earned a revenue of €4.76 billion and had a net profit of €213.03 million

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).